Bioxcel therapeutics inc.

Major-Pharmaceuticals

BTAI


555 Long Wharf Drive
New Haven , CT 06511

Executive/
Director

Price

  • Last Close
  • $ 0.4
    $ +0.01 3.59 %
    Jan 3, 2025
  • 52-Week High/Low
  • $5.51 - $0.6
  • YTD
  • 7.2%

  • Trading Volume
  • 11,914
  • Market Cap Full
  • $ 11.7M
  • Shares Outstanding
  • 29.3M
    Nov 10, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - - 156.2% -5% -8.2% 2.9% -13.1% -4.2% 7.2%
Q2 - - -15.1% 16.6% 4% -31.5% -36.9% -64.3% -55.5% -
Q3 - - -16.6% -33.2% 8% 4.4% -10.5% -62% -43.3% -
Q4 - - -49.3% 50.7% 6.6% -33% 81.7% 21.4% -20.3% -
J F M A M J J A S O N D
2025 7.2% - - - - - - - - - - -
2024 9.2% -1.2% -11.2% 0.5% -38.4% -28% -11.1% -43.3% - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%0%193%309%-56%6%-86%-87%7%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - -0.37 -0.46 -0.79 -1.08 -1.12 -1.84
Q2 - - -0.19 -0.54 -1.06 -1.11 -1.35 -1.83
Q3 - - -0.31 -0.57 -1.07 -0.96 -1.49 -1.72
Q4 - - -0.45 -0.45 -0.87 -0.9 -1.96 -
A 0 0 -1.3 -2 -3.8 -4.1 -5.9 -5.39

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 15.7 20.2 24.6 28 29
Jun 15.6 15.7 20.2 24.6 28 29.2
Sep 15.6 15.7 22.4 28 28 29.3
Dec 15.6 18 24.4 28 28 29.3

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio 0.5 - - - -
Debt – Equity Ratio 1.2 - - - -
Interest Coverage -26.7 - - 34 20
Equity multiplier - - - - -